CAL
BIO icon

Capital Analysts LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital Analysts LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-139
Closed -$49K – 704
2020
Q1 		$49K Sell
139
-41
-23% -$15.1K 0.01% 339
2019
Q4 		$67K Hold
180
– – 0.01% 351
2019
Q3 		$59K Hold
180
– – 0.01% 358
2019
Q2 		$56K Sell
180
-22
-11% -$6.59K 0.01% 354
2019
Q1 		$61K Sell
202
-33
-14% -$8.9K 0.01% 327
2018
Q4 		$55K Hold
235
– – 0.01% 309
2018
Q3 		$74K Sell
235
-116
-33% -$36K 0.01% 274
2018
Q2 		$101K Sell
351
-37
-10% -$10.2K 0.01% 247
2018
Q1 		$97K Sell
388
-61
-14% -$15.5K 0.01% 246
2017
Q4 		$107K Sell
449
-253
-36% -$61.3K 0.01% 230
2017
Q3 		$156K Sell
702
-49
-7% -$11K 0.02% 200
2017
Q2 		$170K Buy
+751
New +$164K 0.02% 205
2016
Q3 		– Sell
-821
Closed -$117K – 401
2016
Q2 		$117K Hold
821
– – 0.02% 194
2016
Q1 		$112K Hold
821
– – 0.02% 206
2015
Q4 		$114K Sell
821
-821
-50% -$114K 0.02% 207
2015
Q3 		$221K Buy
1,642
+997
+155% +$143K 0.04% 179
2015
Q2 		$97.1K Hold
645
– – 0.02% 216
2015
Q1 		$87.2K Hold
645
– – 0.02% 214
2014
Q4 		$77.8K Hold
645
– – 0.02% 212
2014
Q3 		$73.1K Buy
645
+163
+34% +$19.3K 0.02% 213
2014
Q2 		$57.7K Buy
482
+59
+14% +$7.2K 0.01% 227
2014
Q1 		$54.2K Hold
423
– – 0.01% 226
2013
Q4 		$52.3K Hold
423
– – 0.01% 214
2013
Q3 		$49.7K Buy
+423
New +$49.9K 0.01% 201

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Analysts LLC's BIO Position: Q2 2020 in Review

Capital Analysts LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 139 shares — an estimated $49K sold.

Capital Analysts LLC first reported a position in BIO in Q3 2013 and held it in 24 quarters. The position peaked at $221K in Q3 2015. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Capital Analysts LLC reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
  • Capital Analysts LLC sold 139 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $49K.
  • Capital Analysts LLC first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and held it in 24 quarters.
  • Capital Analysts LLC's Bio-Rad Laboratories Class A position peaked at $221K in Q3 2015.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Capital Analysts LLC's 13F filing for Q2 2020, filed 7 Aug 2020.